≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified disorders of white blood cells

DOID EFO Endpoint Browser PheWeb

D3_WHITEBLOODCELLNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D72.8, D72.9
  • Hospital discharge: ICD-9 — 288[8-9]
  • Cause of death: ICD-10 — D72.8, D72.9
  • Cause of death: ICD-9 — 288[8-9]

2 out of 7 registries used, show all original rules.

1489

4. Check minimum number of events

None

1489

5. Include endpoints

None

1489

6. Filter based on genotype QC (FinnGen only)

1489

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11640 6110 5442
Only index persons 9637 5134 4503
Unadjusted period prevalence (%)
Whole population 0.16 0.18 0.15
Only index persons 0.18 0.19 0.17
Median age at first event (years)
Whole population 59.46 58.68 60.22
Only index persons 57.31 56.07 58.71

-FinnGen-

Key figures

All Female Male
Number of individuals 1489 795 694
Unadjusted period prevalence (%) 0.29 0.27 0.31
Median age at first event (years) 56.74 52.20 61.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1373
Matched controls
13730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
10013.2
323.0
1082
5
XW000
NOMESCO Finland
Bone marrow biopsy
34.1
323.0
432
182
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
797.3
273.0
260
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.7
194.7
300
183
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
62.8
183.3
213
40
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
78.8
114.7
129
18
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.7
93.7
373
1013
D70.89
ICD-10 Finland
Neutropenic splenomegaly
295.3
82.5
83
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.0
77.6
99
28
2888B
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]
+∞
72.5
69
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
189.7
69.8
72
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
65.9
740
4155
L01XX05
ATC
hydroxycarbamide; oral
28.4
57.1
78
29
M04AA01
ATC
allopurinol; systemic
3.5
53.7
282
932
R50.9
ICD-10 Finland
Fever, unspecified
3.3
49.8
291
1035
189
Kela drug reimbursment
Imatinib
71.4
48.4
55
8
L03AA02
ATC
filgrastim; parenteral
9.8
47.2
98
107
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
44.9
412
1945
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.0
44.4
77
58
L01XE01
ATC
[U] imatinib; oral
63.4
42.5
49
8
WW500
NOMESCO Finland
Blood transfusion
6.4
42.1
116
196
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
51.8
41.9
50
10
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
40.8
39
*
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
66.4
39.3
45
7
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
366.5
36.1
36
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
36.1
215
761
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
33.3
137
360
JN4BD
NOMESCO Finland
Extensive body CT
2.9
30.7
211
819
C91.7
ICD-10 Finland
Other lymphoid leukaemia
+∞
30.3
29
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
59.8
30.2
35
6
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
44.8
28.8
35
8
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
28.7
173
614
J01MA12
ATC
levofloxacin; systemic
2.3
28.5
306
1514
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
49.7
28.5
34
7
H02AB06
ATC
prednisolone; systemic
1.9
28.3
658
4473
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
26.2
325
1713
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
25.6
176
680
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
13.3
25.3
44
34
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
71.2
24.9
28
*
ZX120
NOMESCO Finland
Intravenous
2.8
24.8
172
668
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
24.1
418
2514
A02BC02
ATC
pantoprazole; systemic
1.8
23.9
881
6830
A04AA01
ATC
ondansetron; systemic, rectal
3.3
23.5
127
416
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
34.0
23.4
30
9
B73
ICPC
Leukaemia
122.0
22.6
24
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
122.0
22.6
24
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
22.6
169
685
127
Kela drug reimbursment
Transplant complication
8.3
22.0
49
61
152
Kela drug reimbursment
Nilotinib
+∞
21.9
21
*
ZXE00
NOMESCO Finland
One hour or less
1.8
21.6
563
3857
316
Kela drug reimbursment
Imatinib
50.8
21.2
25
5
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
37.8
20.8
26
7
C03CA01
ATC
furosemide; systemic
1.9
20.8
400
2470
L01BB05
ATC
fludarabine; systemic
78.0
20.7
23
*
WW200
NOMESCO Finland
Immunization
5.1
20.4
65
132
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
20.2
442
2848
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
20.0
96
287
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
20.0
112
375
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
7.8
20.0
46
61
Z2221
NOMESCO Finland
Medical doctor
1.8
19.8
404
2539
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
74.6
19.7
22
*
J01DB01
ATC
cefalexin; oral
1.9
19.7
1098
9376
Z3231
NOMESCO Finland
Registered nurse
1.8
19.7
396
2479
H02AB09
ATC
hydrocortisone; systemic
5.3
19.5
60
117
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
19.1
230
1180
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
19.1
289
1628
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
24.1
18.7
26
11
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
18.6
679
5067
1512
Kela drug reimbursment
Ibrutinib
67.5
17.7
20
*
390
Kela drug reimbursment
Ibrutinib
67.5
17.7
20
*
J01MA14
ATC
moxifloxacin; systemic
2.5
17.0
141
600
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
16.8
124
495
D72.1
ICD-10 Finland
Eosinophilia
+∞
16.7
16
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
16.7
375
2410
JN4AD
NOMESCO Finland
Body CT examination
2.6
16.5
123
494
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
16.4
493
3446
J05AB11
ATC
valaciclovir; oral
2.2
16.0
183
915
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
15.7
130
554
2888A
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]
+∞
15.6
15
*
L01XX28
ATC
[D] imatinib; oral
+∞
15.6
15
*
150
Kela drug reimbursment
Dasatinib
86.1
15.6
17
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
15.6
252
1444
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
38.5
15.4
19
5
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
15.2
83
275
L04AD01
ATC
ciclosporin; systemic
5.3
15.1
46
90
D75.2
ICD-10 Finland
Essential thrombocytosis
57.3
14.8
17
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
14.7
57
143
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
14.7
289
1769
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
151.5
14.5
15
*
399
Kela drug reimbursment
Venetoclax
151.5
14.5
15
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
36.4
14.5
18
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
14.3
123
536
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.0
14.2
45
92
212
Kela drug reimbursment
Gout
4.7
13.8
46
100
R03BB04
ATC
tiotropium bromide; inhalant
2.2
13.7
145
697
L01XE06
ATC
[U] dasatinib; systemic
75.9
13.6
15
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.4
13.6
67
207
L01XE27
ATC
[U] ibrutinib; oral
141.3
13.5
14
*
L01XX52
ATC
venetoclax; oral
141.3
13.5
14
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
13.3
523
3866
TGC00
NOMESCO Finland
Bronchial lavation
4.1
13.0
50
125
R4110
NOMESCO Finland
Physiotherapy
1.7
13.0
353
2371
A05AA02
ATC
ursodeoxycholic acid; oral
5.3
12.9
39
76
L01AA02
ATC
chlorambucil; oral
19.2
12.9
19
10
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
12.8
140
684
D45
ICD-10 Finland
Polycythaemia vera
8.1
12.8
28
35
WX892
NOMESCO Finland
Monitored bed care
2.4
12.8
110
480
N06AX16
ATC
venlafaxine; oral
2.0
12.7
174
931
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
15.6
12.6
20
13
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
70.5
12.6
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
12.6
89
348
L01XE08
ATC
[U] nilotinib; oral
+∞
12.5
12
*
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.5
1122
10009
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
12.5
227
1346
Z2446
NOMESCO Finland
Social worker
2.5
12.4
102
435
Z3226
NOMESCO Finland
Physiotherapist
1.8
12.4
255
1575
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
12.3
122
572
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
12.2
81
306
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.4
12.1
43
100
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
12.1
224
1336
L03AA13
ATC
pegfilgrastim; parenteral
3.4
12.0
57
171
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
12.0
284
1826
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
11.9
172
942
WX110
NOMESCO Finland
Local anesthesy
1.5
11.9
864
7269
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
11.8
215
1276
A07AA02
ATC
nystatin; oral
2.5
11.8
91
374
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
11.8
62
202
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
11.7
204
1190
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.1
11.7
31
52
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
65.5
11.6
13
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
19.1
11.6
17
9
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
11.6
152
802
J01MA02
ATC
ciprofloxacin; systemic
1.5
11.5
491
3671
R53
ICD-10 Finland
Malaise and fatigue
1.7
11.3
261
1666
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
25.2
11.1
15
6
N03AX16
ATC
pregabalin; oral
1.6
11.1
293
1939
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.9
11.1
68
244
ZX108
NOMESCO Finland
Inhalation
8.6
11.0
23
27
N05AA02
ATC
levomepromazine; systemic
2.8
11.0
69
252
L01EL01
ATC
ibrutinib; oral
43.7
10.9
13
*
J01CA04
ATC
amoxicillin; systemic
1.5
10.9
1034
9125
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
10.9
432
3165
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
10.8
414
3007
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
28.3
10.7
14
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
10.7
131
670
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
10.7
93
407
120
Kela drug reimbursment
Hypogammaglobulinaemia
60.5
10.6
12
*
ZX112
NOMESCO Finland
Subcutaneous
4.1
10.6
40
100
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
10.5
187
1099
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
110.8
10.4
11
*
L01EA03
ATC
nilotinib; oral
+∞
10.4
10
*
328
Kela drug reimbursment
Nilotinib
+∞
10.4
10
*
R06.0
ICD-10 Finland
Dyspnoea
1.6
10.3
313
2142
J02AC03
ATC
voriconazole; systemic
32.8
10.3
13
*
JN6AD
NOMESCO Finland
CT of torso and neck
6.1
10.3
27
45
ZY010
NOMESCO Finland
Hospital outpatient
2.7
10.3
68
256
N05BA01
ATC
diazepam; systemic, rectal
1.8
10.2
173
1001
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.2
10.1
52
167
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
10.1
114
565
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
10.1
255
1664
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
10.0
497
3806
N02AX02
ATC
tramadol; systemic, rectal
1.5
10.0
525
4069
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
9.2
10.0
20
22
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
40.4
10.0
12
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
9.9
54
181
A46
ICD-10 Finland
Erysipelas
1.8
9.9
185
1103
WX402
NOMESCO Finland
General anaesthesia
1.7
9.9
206
1273
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
26.2
9.8
13
5
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.8
9.8
20
23
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.6
202
1248
L04AA06
ATC
mycophenolic acid; systemic
4.4
9.5
33
76
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.1
9.5
18
18
324
Kela drug reimbursment
Dasatinib
100.7
9.4
10
*
1518
Kela drug reimbursment
NA
100.7
9.4
10
*
D75.1
ICD-10 Finland
Secondary polycythaemia
30.2
9.4
12
*
N06AX21
ATC
duloxetine; oral
2.0
9.4
129
692
C83.1
ICD-10 Finland
Mantle cell lymphoma
12.4
9.4
16
13
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.4
251
1662
N05CF01
ATC
zopiclone; oral
1.5
9.3
394
2909
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
9.2
99
481
L01AA01
ATC
cyclophosphamide; systemic
7.8
9.1
20
26
N05BA04
ATC
oxazepam; oral
1.6
9.1
292
2020
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.1
9.1
48
158
N03AE01
ATC
clonazepam; systemic
2.3
9.1
80
355
R60.0
ICD-10 Finland
Localized oedema
1.9
8.9
139
782
E0000UV
ATC
NA
1.4
8.9
474
3662
B01AB05
ATC
enoxaparin; parenteral
1.5
8.9
369
2710
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
8.8
131
724
A28
ICPC
Limited function/disability NOS
1.7
8.8
182
1118
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
8.7
90
429
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
50.3
8.7
10
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
8.7
73
318
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
8.7
90
431
AA1AD
NOMESCO Finland
CT of head and brain
1.5
8.6
285
1985
R03AC02
ATC
salbutamol; inhalant
1.4
8.6
639
5246
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
8.5
139
791
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
8.5
454
3499
B99
ICPC
Blood/lymph/spleen disease other
9.0
8.5
17
19
J01AA02
ATC
doxycycline; systemic
1.4
8.5
978
8683
T90
ICPC
Diabetes non-insulin dependent
1.5
8.5
278
1934
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.4
8.5
19
26
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
8.5
128
714
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.7
8.4
27
58
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.7
8.4
20
30
N02AA05
ATC
oxycodone; systemic
1.7
8.4
181
1128
A02BC01
ATC
omeprazole; systemic
1.5
8.3
343
2514
ZXD05
NOMESCO Finland
Urgent procedure
1.5
8.2
391
2948
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
8.2
550
4422
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
8.2
148
873
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.1
464
3621
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.4
8.1
65
274
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
33.5
8.1
10
*
SPAT1263
SPAT
Sampling
1.4
7.9
516
4122
C03DA01
ATC
spironolactone; oral
1.8
7.9
130
745
N06AB04
ATC
citalopram; systemic
1.5
7.8
253
1752
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
7.8
69
309
C91.4
ICD-10 Finland
Hairy-cell leukaemia
45.2
7.7
9
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.5
7.7
34
99
RS220
NOMESCO Finland
NA
4.6
7.7
25
55
TAB00
NOMESCO Finland
Lumbar puncture
2.4
7.7
60
252
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
7.7
147
882
N03AX12
ATC
gabapentin; oral
1.7
7.7
179
1138
J05AB01
ATC
aciclovir; systemic
1.6
7.7
243
1672
R4120
NOMESCO Finland
Occupational therapy
2.1
7.6
83
408
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
7.6
66
293
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
7.6
76
360
J01FF01
ATC
clindamycin; systemic
1.5
7.6
331
2445
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
7.6
32
90
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
7.6
207
1376
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
7.6
71
327
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.2
7.5
19
31
N05CD07
ATC
temazepam; oral
1.7
7.5
148
899
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.5
95
495
B01AB10
ATC
tinzaparin; parenteral
2.0
7.5
89
453
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
7.5
222
1502
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
80.5
7.4
8
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
80.5
7.4
8
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
80.5
7.4
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.4
164
1027
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
13.4
7.4
12
9
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.0
7.4
19
32
B02.9
ICD-10 Finland
Zoster without complication
2.1
7.4
77
373
UJF32
NOMESCO Finland
Coloscopy
1.5
7.3
311
2282
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
+∞
7.3
7
*
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
7.3
7
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
7.3
7
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
9.4
7.3
14
15
H02AB07
ATC
prednisone; oral
1.6
7.2
175
1124
L28
ICPC
Limited function/disability (L)
1.6
7.2
182
1182
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
20.1
7.1
10
5
SPAT1254
SPAT
Administration of medicine
1.6
7.1
178
1154
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.3
7.0
24
56
ZXA05
NOMESCO Finland
Left side
1.5
7.0
305
2243
N05AH02
ATC
clozapine; systemic
3.5
7.0
30
86
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
7.0
95
511
A02BC05
ATC
esomeprazole; systemic
1.4
6.9
472
3779
J01FA10
ATC
azithromycin; systemic
1.3
6.8
670
5683
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.2
6.8
24
58
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.5
6.8
22
49
R06AE07
ATC
cetirizine; oral
1.4
6.8
498
4034
WW409
NOMESCO Finland
Other aferesis
40.2
6.8
8
*
N05AH04
ATC
quetiapine; oral
1.6
6.7
182
1204
N06AX11
ATC
mirtazapine; oral
1.4
6.7
361
2766
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.9
6.7
39
139
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
22.6
6.7
9
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
22.6
6.7
9
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
22.6
6.7
9
*
R31
ICD-10 Finland
Unspecified haematuria
1.7
6.7
125
748
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.1
6.7
72
355
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
6.7
67
320
N03AX09
ATC
lamotrigine; oral
2.3
6.6
56
245
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.6
273
1987
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.9
6.6
94
516
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.5
225
1574
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.2
6.5
31
97
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
6.5
465
3741
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.2
6.5
23
56
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
6.5
52
221
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.1
6.5
19
38
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.7
6.5
26
71
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.8
6.5
113
661
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
6.5
317
2388
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.5
195
1324
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.4
6.5
50
211
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.5
209
1444
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
6.4
89
482
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
6.4
136
843
D69.4
ICD-10 Finland
Other primary thrombocytopenia
70.2
6.4
7
*
B02BX05
ATC
eltrombopag; oral
70.2
6.4
7
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.5
6.4
46
186
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
14.4
6.4
10
7
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.7
6.4
26
72
D07AB08
ATC
desonide; topical
1.7
6.4
129
789
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
6.4
45
180
Z2445
NOMESCO Finland
Psychologist
2.4
6.3
51
218
RD210
NOMESCO Finland
NA
3.5
6.3
27
78
A06AD11
ATC
lactulose; oral
1.6
6.3
164
1075
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
6.3
86
465
R02
ICPC
Shortness of breath/dyspnoea
1.6
6.3
144
912
L01BB02
ATC
mercaptopurine; oral
4.6
6.3
20
44
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.2
6.3
62
294
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
18.1
6.3
9
5
ZX131
NOMESCO Finland
Intrathecal
+∞
6.3
6
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
6.3
6
*
2888X
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOPATHIA ALIA DEFINITA]
+∞
6.3
6
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
6.3
6
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
6.3
64
308
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
26.8
6.2
8
*
N05AX08
ATC
risperidone; systemic
1.9
6.2
87
473
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.5
6.2
47
194
N07BA03
ATC
varenicline; oral
2.2
6.2
63
300
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.1
190
1300
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
6.1
152
986
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
6.1
282
2096
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.9
6.1
23
60
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
6.1
84
456
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.6
6.1
12
14
9101
FHL
Bone biopsy
10.1
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042111) Morphology [Interpretation] in Bone marrow Narrative
270
161
20.26
307.65
1.9
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
677
1321
8.56
307.65
9.3
3.8
u/l
247.8
248.3
0.02
647
1240
(3045142) Bone marrow Pathology biopsy report
210
103
23.57
282.17
1.4
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
201
99
23.32
269.36
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
587
1345
6.55
261.92
5.6
2.5
%
1.8
1.8
0.04
551
1188
(42870588) Differential panel, method unspecified - Blood
1024
4068
5.86
236.93
14.2
5.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
479
994
6.63
234.35
6.2
2.5
e9/l
73.1
69.6
0.98
370
765
(3005719) IgG [Mass/volume] in Serum or Plasma
433
901
6.37
209.29
3.9
2.7
g/l
9.2
10.8
7.95
394
826
(3022096) Basophils/100 leukocytes in Blood
1125
5463
5.33
185.87
15.1
5.8
%
0.6
0.7
1.20
1086
5082
(3019069) Monocytes/100 leukocytes in Blood
1147
5659
5.47
185.55
16.4
6.1
%
8.3
8.6
1.31
1105
5284
(3006504) Eosinophils/100 leukocytes in Blood
1143
5633
5.43
184.90
15.4
5.8
%
2.4
2.8
6.14
1101
5231
(3002030) Lymphocytes/100 leukocytes in Blood
1154
5803
5.39
179.80
15.6
5.9
%
36.2
27.5
36.42
1103
5396
(3004809) Band form neutrophils/100 leukocytes in Blood
187
174
12.15
177.33
6.5
3.1
%
0.8
1.3
0.81
157
142
(3017181) Myelocytes/100 leukocytes in Blood
411
974
5.45
169.39
9.3
4.2
%
0.7
0.8
0.78
252
271
(3018010) Neutrophils/100 leukocytes in Blood
1125
5733
4.94
167.00
14.2
5.7
%
49.9
57.5
32.88
1079
5355
(3028026) IgM [Mass/volume] in Serum or Plasma
343
703
6.04
165.79
2.3
1.8
g/l
1.6
1.5
0.18
303
649
(3011412) CD3 cells [#/volume] in Blood
138
92
16.43
159.03
3.6
2.2
e9/l
1.2
1.1
0.30
85
52
(3000093) Morphology [Interpretation] in Blood Narrative
142
102
15.28
157.15
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
375
887
5.31
153.75
9.2
4.0
%
0.3
0.5
0.97
203
200
(3006315) Basophils [#/volume] in Blood
1132
6007
4.69
153.41
13.5
5.7
e9/l
0.1
0.0
0.98
1029
5179
(3001604) Monocytes [#/volume] in Blood
1125
5982
4.60
150.99
13.5
5.7
e9/l
0.7
0.6
6.19
1018
5151
(3013115) Eosinophils [#/volume] in Blood
1148
6218
4.70
149.54
15.3
5.9
e9/l
0.2
0.2
1.97
1055
5449
(21494815) CD4 cells/100 lymphocytes in Specimen
130
88
16.09
148.46
3.1
2.0
%
27.9
42.7
1.80
18
11
(3019198) Lymphocytes [#/volume] in Blood
1136
6150
4.57
146.92
13.8
5.7
e9/l
5.8
2.0
13.07
1059
5406
(3021440) Promyelocytes/100 leukocytes in Blood
373
924
5.05
144.11
9.6
4.2
%
0.1
0.1
0.92
245
249
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
205
284
8.21
143.37
2.4
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
114
70
17.55
136.75
2.5
2.1
%
11.6
12.3
0.14
53
33
(3025159) Blasts/100 leukocytes in Blood
349
872
4.92
132.65
9.3
4.3
%
0.2
0.5
0.26
212
211
(3020630) Protein [Mass/volume] in Serum or Plasma
363
980
4.58
124.65
2.2
2.9
g/l
66.3
66.3
0.02
338
889
(3013650) Neutrophils [#/volume] in Blood by Automated count
1177
6974
4.28
123.18
21.0
8.7
e9/l
4.6
4.1
3.09
1095
6080
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
103
64
17.22
122.67
2.5
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
320
811
4.75
118.63
2.1
2.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
100
69
15.46
112.66
3.8
2.3
e6/l
941.0
566.9
0.44
80
60
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
159
226
7.76
108.04
7.8
5.4
iu/ml
396.2
978.5
0.43
23
30
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
243
539
5.19
105.11
2.4
1.8
g/l
1.3
1.5
3.84
208
465
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
94
67
14.91
103.94
4.0
2.4
e9/l
0.2
0.2
0.19
80
60
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1068
6302
3.46
103.85
10.9
6.0
umol/l
10.5
11.6
3.59
1031
5972
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
93
69
14.31
100.51
2.6
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
93
69
14.31
100.51
2.6
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
115
125
9.89
96.86
9.5
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
131
178
7.97
92.30
3.2
2.9
u/ml
795.2
2880.4
—
9
14
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
94
83
12.02
91.33
4.1
2.1
e6/l
1690.8
683.8
0.37
38
32
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
128
177
7.82
88.78
1.5
1.2
u/l
59.3
46.0
0.24
115
156
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
140
219
6.95
86.85
1.3
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
101
108
9.96
85.98
6.8
3.0
%
42.0
54.1
2.81
64
78
(40760892) CBC W Ordered Manual Differential panel - Blood
574
2611
2.95
83.96
10.8
4.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
638
3115
2.83
81.13
5.4
2.7
umol/l
2658.8
6333.2
1.85
581
2684
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
192
434
4.93
80.43
1.9
2.6
g/l
3.1
3.1
0.10
160
345
(3021589) Normoblasts [#/volume] in Blood
909
5339
2.80
80.20
21.3
9.5
e9/l
0.0
0.0
1.82
783
4372
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
127
197
6.95
79.29
1.4
1.4
u/ml
105.1
130.4
0.58
23
39
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
183
402
5.05
79.27
2.0
2.9
g/l
0.4
1.1
1.97
165
352
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
196
460
4.76
78.39
1.9
2.6
g/l
3.5
3.8
1.46
160
340
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
196
461
4.74
78.18
1.9
2.6
g/l
7.0
7.4
1.26
161
352
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
196
461
4.74
78.18
1.9
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
189
433
4.85
77.83
1.9
2.6
g/l
9.8
10.4
0.83
163
369
(3018418) pH of Serum or Plasma
686
3545
2.73
77.16
7.3
3.9
ph
7.4
7.4
1.25
160
663
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
172
375
5.06
75.05
1.8
2.5
g/l
38.4
37.5
0.90
155
325
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
168
359
5.15
75.04
1.8
2.6
g/l
0.2
0.0
0.46
156
330
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
161
338
5.22
73.35
1.8
2.6
g/l
0.0
0.0
0.50
149
310
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
964
6016
2.71
72.34
11.1
6.8
mmol/l
1.2
1.2
0.45
795
5089
(21494814) CD8 cells/100 lymphocytes in Specimen
60
36
17.32
72.33
2.6
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
401
1616
3.03
71.40
3.3
2.5
%
22.7
22.7
0.02
359
1373
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
158
335
5.16
71.12
1.8
2.7
g/l
0.0
0.0
0.00
149
309
(3003458) Phosphate [Moles/volume] in Serum or Plasma
400
1624
3.00
70.14
8.7
5.7
mmol/l
1.0
1.0
0.42
379
1501
(3023368) Bacteria identified in Blood by Culture
645
3352
2.63
70.08
6.8
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
501
2299
2.78
69.82
1.9
1.5
g/l
2.1
2.5
4.14
368
1382
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
897
5472
2.61
69.39
10.2
6.1
mmol/l
1.2
1.2
0.54
840
4959
(40758558) Short blood count panel - Blood
593
2999
2.62
67.61
14.9
6.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
432
1880
2.83
66.15
3.2
2.5
umol/l
12.4
12.9
0.77
405
1731
(3004789) Transferrin [Mass/volume] in Serum or Plasma
410
1736
2.88
66.11
3.2
2.5
g/l
2.3
2.3
0.14
385
1604
(3024561) Albumin [Mass/volume] in Serum or Plasma
855
5208
2.51
64.63
7.1
4.8
g/l
34.9
35.4
1.60
802
4845
(3021879) Hepatitis B virus core Ab [Presence] in Serum
253
826
3.49
63.48
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
124
236
5.64
62.81
5.6
3.8
%
49.8
58.6
4.71
124
236
(3012095) Magnesium [Moles/volume] in Serum or Plasma
435
1957
2.73
61.92
6.1
3.3
mmol/l
0.8
0.8
0.75
413
1828
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
122
235
5.57
60.98
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
442
2021
2.69
60.77
1.7
1.8
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
155
374
4.51
59.43
2.3
3.8
ratio
1.2
1.6
—
10
34
(3034860) Kappa light chains.free [Mass/volume] in Serum
156
382
4.44
58.68
2.3
3.9
mg/l
47.0
67.9
0.59
129
311
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
156
383
4.43
58.48
2.3
3.9
mg/l
39.0
77.9
0.62
129
313
(3048879) Bone marrow aspiration report
49
30
16.86
58.36
2.6
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1246
9337
3.05
57.66
15.4
7.3
u/l
83.3
78.4
3.05
1212
8772
(3000060) B lymphocytes [#/volume] in Blood
46
27
17.55
55.91
2.4
2.4
e6/l
3558.1
261.5
0.73
31
13
(3048929) Epstein Barr virus Ab [Presence] in Serum
146
361
4.38
54.14
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
45
27
17.15
54.09
2.6
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
35
11
32.56
53.94
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
318
1304
2.83
53.28
1.5
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
111
223
5.30
52.86
1.3
1.3
u/ml
252.7
271.9
0.23
75
131
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
42
24
17.98
51.66
1.3
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
49
38
13.30
51.31
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
62
72
8.94
49.36
2.6
2.8
%
39.5
43.3
0.29
18
21
(40760888) Immunoglobulin light chains.free panel - Serum
121
287
4.50
47.21
2.4
4.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1180
8963
2.53
46.34
6.6
4.0
mm/h
14.6
12.2
4.66
1124
8260
(4035726)
260
1029
2.85
46.07
1.5
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
462
2419
2.32
45.34
3.5
2.8
mosm/kgh2o
533.4
552.6
1.10
409
2053
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
358
1678
2.49
45.06
1.6
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
71
108
6.85
44.89
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
553
3130
2.22
44.86
2.9
2.2
mg/l
3.3
3.0
1.64
477
2631
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
116
278
4.44
44.64
3.1
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
545
3072
2.22
44.62
6.6
3.9
%
88.2
89.6
0.70
533
2996
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
132
349
4.05
44.61
2.9
2.7
g/l
3.6
3.6
0.08
127
331
(3037756) Immunofixation for Serum or Plasma
111
258
4.57
44.39
1.4
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
999
7138
2.21
44.22
7.2
4.9
mmol/l
6.7
6.7
0.25
957
6678
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
311
1375
2.59
44.19
5.3
2.7
umol/l
7.4
8.3
0.24
278
1209
(3001122) Ferritin [Mass/volume] in Serum or Plasma
802
5266
2.13
44.19
4.1
2.8
ug/l
216.3
127.2
2.28
743
4827
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
117
285
4.37
44.08
3.0
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
566
3252
2.19
44.05
4.3
3.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
73
117
6.51
43.92
2.3
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
340
1578
2.50
43.56
1.5
1.3
titre
538.7
481.1
0.21
75
329
(3002582) Erythrocytes [#/volume] in Urine
615
3668
2.15
43.35
4.4
3.3
e6/l
103.5
85.4
0.10
512
2848
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
96
203
4.99
43.02
3.3
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
382
1884
2.38
42.69
3.0
2.1
s
30.4
29.8
0.81
374
1824
(3000012) Reticulocyte production index
54
65
8.58
41.75
2.3
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
40
32
12.82
41.04
6.2
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
632
3880
2.09
40.60
4.9
3.2
u/l
38.7
34.1
0.80
607
3688
(3030467) Casts [#/volume] in Urine by Automated count
566
3349
2.11
39.97
4.3
3.2
e6/l
0.4
0.4
0.72
471
2551
(3018095) Leukocytes [#/volume] in Urine
673
4289
2.04
38.46
5.2
3.8
e6/l
76.0
107.1
0.58
541
3064
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
73
134
5.68
38.26
2.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
69
123
5.83
37.29
1.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
381
1976
2.25
37.19
2.9
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
453
2564
2.10
35.11
3.5
2.6
e6/l
6.2
5.7
0.11
408
2241
(4062490)
60
103
6.03
33.69
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
59
100
6.10
33.56
1.3
1.3
g/l
6.5
7.2
0.25
33
70
(3024139) IgG subclass 3 [Mass/volume] in Serum
59
100
6.10
33.56
1.3
1.3
g/l
0.4
0.4
0.02
32
69
(3028192) IgG subclass 2 [Mass/volume] in Serum
59
100
6.10
33.56
1.3
1.3
g/l
2.3
2.6
0.43
33
69
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
39
7
57.14
33.36
9.5
4.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
44
55
8.21
32.97
5.6
3.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
127
403
3.35
32.61
1.7
1.6
titre
88.0
132.9
—
5
17
(3032080) INR in Blood by Coagulation assay
728
4960
1.92
32.51
10.4
9.7
inr
1.2
1.3
0.27
256
1432
(3036481) Cortisol [Moles/volume] in Serum or Plasma
248
1130
2.43
32.28
2.5
2.2
nmol/l
352.8
372.6
0.86
235
1037
(3024980) IgG subclass 4 [Mass/volume] in Serum
76
173
4.58
31.11
1.4
1.7
g/l
0.7
0.9
0.40
47
131
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
76
173
4.58
31.11
2.0
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
47
69
7.00
30.66
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
280
1376
2.27
30.52
2.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
279
1380
2.26
29.89
2.4
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
194
818
2.58
29.67
3.5
2.9
e9/l
4.5
4.1
0.64
152
641
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
721
5005
1.85
29.37
2.4
2.0
pmol/l
93.3
94.6
0.35
422
2624
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
94
262
3.76
29.36
1.9
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
447
2663
1.97
29.13
2.2
1.7
mg/l
1.1
1.2
0.68
351
2035
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
43
62
7.11
28.50
3.2
2.7
u/ml
1640.6
1234.8
0.35
43
62
(3019309) Folate [Moles/volume] in Red Blood Cells
395
2291
1.99
27.58
2.2
1.7
nmol/l
1245.5
1176.9
0.72
323
1718
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
198
872
2.47
27.54
2.1
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
112
365
3.24
27.48
2.1
1.5
g/l
1.1
1.2
2.46
105
343
(3020779) Urea [Moles/volume] in Serum or Plasma
229
1079
2.33
27.36
10.5
7.5
mmol/l
10.6
9.9
0.77
217
1024
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
109
353
3.25
27.02
2.2
1.5
g/l
0.2
0.2
1.79
99
333
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
574
3788
1.84
26.85
3.0
2.5
u/l
54.6
57.0
0.87
538
3497
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
79
212
3.88
26.03
1.9
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
612
4147
1.81
26.03
4.1
3.3
mmol/l
2.3
2.4
0.57
555
3618
(3042936) Bacteria identified in Isolate by Culture
325
1794
2.04
25.89
2.4
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
88
256
3.59
25.80
4.7
3.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
101
325
3.26
25.29
6.4
4.3
mg/l
1.5
1.6
0.23
95
295
(3037467) Urinalysis macro (dipstick) panel - Urine
1046
8395
1.83
24.15
5.9
4.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
50
99
5.19
24.12
2.2
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
693
4946
1.75
24.10
3.0
2.3
nmol/l
76.4
77.0
0.20
639
4425
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
71
6.06
23.94
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
102
342
3.13
23.85
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
117
428
2.88
23.46
3.0
2.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
204
979
2.26
23.15
5.6
3.6
mmol/l
1.2
1.2
2.69
183
842
(40758292) HTLV I+II Ab panel - Serum
20
13
15.58
22.82
1.1
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1365
12098
2.54
22.77
31.0
14.3
mg/l
23.1
24.7
0.97
1208
9591
(3021960) Folate [Moles/volume] in Serum or Plasma
456
2929
1.80
22.46
2.0
1.5
nmol/l
21.0
20.7
0.17
418
2481
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
380
2331
1.85
21.65
3.9
3.8
ng/l
431.2
377.2
0.13
304
1834
(3031040) Bacteria [#/volume] in Urine by Automated count
1000
8041
1.74
21.55
6.0
4.4
e6/l
261.3
2442.3
1.85
26
119
(4212803)
26
6
44.02
21.44
1.2
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
331
1949
1.90
21.42
3.7
3.0
e6/l
2.8
2.4
0.29
205
1092
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
242
1289
2.05
20.90
4.7
3.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
81
256
3.29
20.88
5.0
4.1
mmol/l
2.5
2.6
0.08
55
168
(3036489) Thrombin time
116
452
2.70
20.62
3.1
2.2
s
21.3
21.8
0.48
110
403
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
533
3652
1.72
20.57
2.9
2.2
u/l
174.6
245.7
1.43
501
3429
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
166
3.85
20.51
2.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
160
728
2.34
20.49
1.7
1.3
u/ml
335.6
226.9
0.40
141
667
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
61
162
3.88
20.41
1.9
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
557
3884
1.69
20.02
4.7
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
66
188
3.63
19.97
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
45
96
4.80
19.94
2.1
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
204
1037
2.12
19.91
4.8
3.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
65
186
3.61
19.54
1.9
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
25
8
31.75
19.28
1.4
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
50
120
4.28
19.17
1.1
1.2
u/l
58.1
53.1
0.29
36
87
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
21
20
10.64
19.14
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
25
9.33
19.12
1.3
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
24
28
8.70
18.92
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
60
168
3.68
18.63
2.7
3.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
133
584
2.40
18.42
7.8
4.1
mmol/l
24.1
24.1
0.11
127
525
(3010421) pH of Blood
88
316
2.90
18.24
5.1
3.8
ph
7.4
7.4
0.07
78
252
(3024471) HLA-A [Type]
23
27
8.64
18.04
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
526
3690
1.66
18.03
3.4
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1173
10066
1.78
17.98
38.0
17.4
%
14.4
13.7
27.05
1161
9837
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
333
2064
1.79
17.91
3.7
2.8
e6/l
0.8
1.3
1.66
210
1201
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
966
7885
1.64
17.76
4.1
3.1
u/l
64.0
49.4
2.25
908
7361
(3000494) Fungus identified in Specimen by Culture
252
1440
1.90
17.57
2.1
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
23
9.25
17.34
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
76
259
3.04
17.29
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
76
259
3.04
17.29
1.5
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
22
26
8.57
17.16
3.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
41
92
4.55
17.11
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
73
245
3.08
17.05
3.8
2.5
%
14.8
16.1
1.88
42
135
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
508
3573
1.64
17.01
3.4
3.0
ng/l
1923.4
1447.2
1.01
432
3043
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
216
1185
1.96
16.97
2.7
2.3
g/l
0.2
0.2
1.72
192
1115
(40768804) Tissue Pathology biopsy report
650
4858
1.60
16.94
2.4
2.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
16
12
13.47
16.81
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
93
362
2.67
16.56
2.5
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
58
172
3.47
16.54
2.9
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
34
67
5.17
16.51
2.2
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
191
1013
2.02
16.50
11.5
9.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
49
130
3.86
16.44
1.9
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
280
1690
1.81
16.31
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
49
133
3.78
15.93
4.1
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
91
359
2.63
15.79
2.2
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
21
26
8.18
15.78
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
92
368
2.60
15.52
5.4
3.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
33
67
5.01
15.50
2.2
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
738
5772
1.55
15.23
6.5
3.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
246
1457
1.82
15.17
1.8
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
45
120
3.84
15.01
4.3
1.6
—
—
—
0
0
(44790047)
49
139
3.61
14.96
1.8
1.6
—
—
—
0
0
(44790048)
49
139
3.61
14.96
1.8
1.6
—
—
—
0
0
(44806118)
49
139
3.61
14.96
1.8
1.6
—
—
—
0
0
(44790049)
49
139
3.61
14.96
1.8
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
750
5916
1.54
14.69
4.5
3.6
estimate
0.0
0.0
0.00
198
1108
(3021901) Oxygen saturation in Capillary blood
66
228
2.98
14.69
4.1
2.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
750
5918
1.54
14.66
6.1
4.9
estimate
0.0
0.0
0.50
201
1126
(3006184) Hemoglobin [Mass/volume] in Capillary blood
73
267
2.82
14.66
3.3
2.2
g/l
117.2
130.0
3.01
50
205
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
83
4.42
14.55
2.1
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
82
321
2.65
14.45
5.0
3.1
mmol/l
25.2
24.9
0.15
74
283
(3012441) Differential panel - Pleural fluid
47
133
3.62
14.40
1.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
42
6.04
14.34
1.7
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
63
215
3.02
14.32
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
91
379
2.49
14.13
1.8
1.6
iu/ml
0.4
0.1
0.42
11
70
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
343
2273
1.66
14.09
3.4
3.0
mmol/l
2.5
2.5
0.11
297
1994
(3003434) Protein [Mass/volume] in Pleural fluid
54
171
3.24
13.92
1.8
1.4
g/l
32.8
31.8
0.20
47
152
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
114
529
2.25
13.88
2.6
2.0
u/l
40.6
38.8
0.30
100
467
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1074
9252
1.58
13.49
4.5
3.9
pmol/l
14.8
14.8
0.00
995
8388
(3002032) Base excess in Venous blood by calculation
197
1131
1.85
13.35
7.0
3.7
mmol/l
1.9
1.9
0.05
164
892
(3009261) Glucose [Presence] in Urine by Test strip
749
5985
1.51
13.30
4.6
3.6
estimate
0.0
0.0
0.28
184
1083
(3014111) Lactate [Moles/volume] in Serum or Plasma
190
1082
1.87
13.20
8.8
7.4
mmol/l
1.5
1.4
0.14
184
1036
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
82
336
2.52
13.19
1.7
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
77
307
2.59
13.10
6.7
3.4
kpa
8.0
8.2
0.72
71
285
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
43
5.66
12.91
6.8
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
43
5.66
12.91
6.8
1.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
13
10.86
12.87
5.1
4.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1356
12472
1.98
12.79
31.6
16.6
mmol/l
139.3
139.6
5.08
1332
12139
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
307
2026
1.65
12.68
1.3
1.3
iu/ml
36.4
32.3
0.23
100
645
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
37
97
3.89
12.66
1.1
1.2
titre
67.1
161.2
—
7
17
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
104
483
2.24
12.64
3.0
1.8
ug/l
2.5
1.9
0.25
94
430
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
44
5.53
12.61
6.8
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
73
290
2.60
12.52
1.4
1.2
u/ml
1.5
2.3
—
9
29
(3023103) Potassium [Moles/volume] in Serum or Plasma
1357
12503
1.96
12.45
32.7
16.7
mmol/l
4.0
4.0
1.64
1330
12152
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
601
4639
1.50
12.33
4.9
3.6
ng/l
120.0
49.5
0.40
438
3233
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
62
229
2.78
12.25
1.3
1.2
u/ml
1.0
6.9
—
5
16
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
73
294
2.56
12.18
1.4
1.2
u/ml
3.4
8.4
0.69
16
50
(3035637) Corticotropin [Mass/volume] in Plasma
45
140
3.28
11.97
1.7
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
193
1140
1.80
11.87
7.0
3.7
kpa
6.0
5.8
1.24
187
1104
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
55
4.79
11.68
6.4
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
55
4.79
11.68
6.4
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
55
4.79
11.68
6.4
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
55
4.79
11.68
6.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
175
1013
1.82
11.50
2.8
2.9
ng/l
258.0
214.4
0.53
154
931
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
190
1128
1.78
11.48
2.9
2.4
u/l
33.6
82.2
0.59
169
949
(3028308) Erythrocytes [#/volume] in Pleural fluid
44
139
3.23
11.43
1.6
1.4
e6/l
215821.8
129690.9
0.22
30
80
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
36
102
3.59
11.06
1.6
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
107
3.52
11.03
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
137
745
1.92
10.92
2.0
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
148
827
1.88
10.87
6.7
3.8
ph
7.4
7.4
0.33
31
95
(3023183) Ammonium ion [Moles/volume] in Plasma
68
280
2.50
10.86
2.3
2.8
umol/l
36.4
33.6
0.40
62
235
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
408
2972
1.51
10.77
4.4
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
25
55
4.61
10.73
1.4
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
221
1395
1.69
10.70
8.8
8.2
kpa
5.1
5.1
0.12
209
1336
(3027801) Oxygen [Partial pressure] in Arterial blood
221
1395
1.69
10.70
8.8
8.2
kpa
11.8
12.0
0.28
209
1338
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
143
795
1.88
10.66
6.7
3.8
mmol/l
2.5
1.8
1.22
104
600
(3041096) Erythrocytes [Presence] in Urine by Automated
437
3247
1.49
10.42
4.5
3.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
148
839
1.85
10.38
6.7
3.8
kpa
5.2
5.2
0.02
135
786
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
59
232
2.61
10.37
1.4
1.2
u/ml
27.3
31.6
—
8
18
(3044889) 12 lead EKG panel
981
8488
1.46
10.35
4.7
3.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
41
132
3.17
10.35
4.0
3.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
31
83
3.79
10.34
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
31
83
3.79
10.34
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
31
83
3.79
10.34
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
41
133
3.14
10.22
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
31
84
3.75
10.17
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
31
84
3.75
10.17
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
31
84
3.75
10.17
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
88
418
2.17
10.15
5.0
2.9
u/ml
0.3
0.4
1.04
53
235
(40768446) Kidney Pathology biopsy report
20
38
5.32
10.12
1.5
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
283
1930
1.58
10.00
1.3
1.3
u/ml
10.8
12.7
0.23
86
731
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
34
100
3.46
9.90
5.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
34
100
3.46
9.90
5.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
34
100
3.46
9.90
5.2
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
50
185
2.76
9.90
1.3
1.2
u/ml
5.7
3.5
0.20
13
56
(3016650) Hepatitis A virus Ab [Presence] in Serum
52
197
2.70
9.84
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
51
193
2.70
9.68
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
101
516
2.03
9.64
1.5
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
49
182
2.75
9.64
1.3
1.2
u/ml
5.0
6.3
0.20
21
78
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
159
948
1.76
9.43
5.1
3.8
ng/l
89.5
86.8
0.14
139
832
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
14
8
17.65
9.40
1.1
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
215
1393
1.64
9.36
9.1
8.2
mmol/l
1.0
1.2
0.20
173
1086
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1371
12857
1.84
9.25
21.0
10.2
u/l
26.8
26.3
0.42
1346
12397
(3001964) Herpes simplex virus Ag [Presence] in Specimen
18
34
5.35
9.17
2.1
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
44
159
2.82
9.12
1.7
1.3
e6/l
1910.6
1540.8
0.26
35
113
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
131
749
1.82
8.94
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
71
327
2.23
8.86
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
356
2615
1.47
8.77
1.8
1.7
pmol/l
23311257.3
40753215.7
0.29
296
2152
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1214
11087
1.51
8.67
5.5
4.7
mu/l
2.0
2.0
0.27
1122
10110
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
25
6.05
8.66
1.5
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
27
75
3.65
8.58
1.5
1.6
u/l
7.4
8.4
0.07
16
37
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
121
3.02
8.50
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1236
11353
1.52
8.36
27.1
13.2
ml/min/173m2
80.5
80.6
0.02
1093
9330
(3007566) Smooth muscle Ab [Titer] in Serum
70
329
2.18
8.33
1.2
1.2
titre
81.4
85.9
—
7
29
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
22
54
4.12
8.27
3.7
4.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
64
3.80
8.08
2.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
64
3.80
8.08
2.2
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
5
22.15
8.02
2.5
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
352
2622
1.45
7.97
1.3
1.3
u/ml
1.5
1.5
0.03
93
691
(3028433) Virus identified in Specimen by Culture
19
43
4.46
7.91
1.6
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
113
649
1.80
7.62
9.7
11.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
6
18.45
7.60
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
24
67
3.62
7.59
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
37
135
2.79
7.58
1.2
1.2
nmol/l
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
190
1256
1.59
7.57
9.5
8.7
%
94.6
95.5
0.97
179
1214
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
56
250
2.29
7.56
2.0
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
69
336
2.10
7.53
1.2
1.2
—
1290.8
—
0
12
(3025941) Bacteria identified in Stool by Culture
115
667
1.78
7.50
1.5
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
47
195
2.46
7.47
1.2
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
118
691
1.77
7.45
2.9
3.5
pmol/l
4.5
4.5
0.01
100
614
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
68
3.57
7.43
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
22
59
3.77
7.36
1.5
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
14
26
5.43
7.25
1.9
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
482
3856
1.37
7.10
3.7
3.3
mmol/l
7.2
7.5
0.73
401
3241
(3019060) Gas panel - Arterial blood
131
802
1.69
7.07
4.9
5.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
129
2.75
7.05
1.9
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
220
1529
1.51
6.99
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
25
76
3.33
6.98
1.5
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
39
154
2.57
6.88
1.3
1.2
nmol/l
0.2
0.5
—
7
14
(3009214) Lutropin [Units/volume] in Serum or Plasma
66
328
2.06
6.85
1.6
1.4
u/l
9.7
9.6
0.00
49
262
(3024354) Oxygen [Partial pressure] in Venous blood
150
960
1.63
6.83
6.8
3.1
kpa
4.6
4.6
0.01
142
926
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
78
3.24
6.71
2.4
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
14
7.18
6.70
2.7
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
452
3606
1.36
6.70
3.7
3.3
mg/l
991.8
291.0
1.31
319
2329
(3029937) Albumin [Presence] in Urine by Test strip
409
3215
1.38
6.64
5.0
3.9
estimate
0.0
0.0
1.28
185
1088
(3022145) Colonoscopy Study observation
197
1354
1.52
6.59
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
472
3802
1.35
6.55
4.7
4.0
mg/mmol
13.3
8.7
1.36
307
2438
(3048689) Calprotectin [Mass/mass] in Stool
204
1416
1.51
6.51
2.5
2.3
ug/g
182.4
126.5
0.76
158
1125
(3003327) Ova and parasites identified in Stool by Light microscopy
72
377
1.96
6.49
1.8
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1337
12634
1.57
6.46
24.4
13.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
38
4.25
6.29
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
129
812
1.64
6.28
2.2
2.4
au/ml
14.4
18.2
—
5
41
(4268621)
32
121
2.68
6.17
2.6
2.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
171
1156
1.54
6.17
9.6
9.2
g/l
115.5
120.6
2.27
162
1117
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
53
3.62
6.04
2.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
53
3.62
6.04
2.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1192
11051
1.39
6.04
32.9
15.4
%
39.0
39.7
2.01
818
7802
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
171
2.38
6.01
1.2
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
27
4.85
5.98
1.1
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
46
210
2.23
5.95
1.6
1.3
mmol/l
60.3
61.6
0.07
39
176
(3000492) Spirometry study
168
1141
1.53
5.93
1.7
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
49
3.71
5.93
1.8
2.1
ug/l
54.0
56.3
0.07
18
49
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
204
2.24
5.92
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
54
3.55
5.89
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
34
136
2.54
5.89
1.4
1.4
pmol/l
442.3
284.5
0.99
27
104
(3004616) Nuclear Ab [Presence] in Serum
34
136
2.54
5.89
1.6
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
842
7436
1.30
5.88
3.3
3.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
35
144
2.46
5.72
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
66
353
1.91
5.62
1.5
1.5
ug/g
283.5
277.3
0.08
45
208
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
21
66
3.21
5.60
2.6
7.2
—
39.6
—
0
20
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
29
110
2.67
5.59
1.1
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
35
146
2.43
5.57
1.6
1.4
mu/l
55.5
42.6
0.30
30
131
(21494890) Protein electrophoresis panel - 24 hour Urine
32
128
2.53
5.55
1.5
2.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
43
3.75
5.37
2.5
2.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
207
2.16
5.32
3.0
2.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
30
4.36
5.30
1.5
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
22
5.03
5.26
1.2
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
44
3.67
5.21
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
64
3.15
5.20
1.1
1.2
u/l
62.4
23.5
1.25
14
44
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
31
4.22
5.09
1.3
1.2
ug/l
115.0
44.8
—
7
14
(3040151) Glucose [Moles/volume] in Capillary blood
33
140
2.39
5.09
10.1
7.8
mmol/l
7.4
7.4
0.02
26
118
(3013512) EKG study
431
3538
1.31
5.01
4.5
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
406
3311
1.31
4.94
1.6
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
543
4601
1.28
4.93
4.9
3.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
497
1.71
4.92
4.0
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
28
4.31
4.83
6.4
4.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
22
78
2.85
4.83
10.2
3.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
29
119
2.47
4.81
3.6
2.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
38
3.71
4.65
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
47
241
1.98
4.58
3.5
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
7
5
14.06
4.58
2.9
1.0
—
—
—
0
0
(4010399)
129
878
1.51
4.54
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
76
456
1.70
4.50
2.1
1.7
—
—
—
0
0
(4198724)
15
44
3.43
4.47
1.9
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
83
513
1.65
4.40
1.4
1.4
iu/l
23.3
28.4
0.83
72
434
(36660697) Celiac disease serology panel - Serum
136
943
1.49
4.38
1.2
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
11
26
4.25
4.36
1.7
1.5
—
185.3
—
0
6
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1184
11126
1.31
4.29
6.7
5.8
mmol/mol
40.1
39.9
0.28
1089
10287
(3051611) Lipemic interference index of Serum or Plasma
29
126
2.33
4.28
8.8
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
55
305
1.83
4.27
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
31
3.89
4.26
1.8
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
91
2.55
4.14
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
68
2.82
4.13
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
80
500
1.63
4.08
2.3
2.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
50
273
1.86
4.08
4.5
2.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
28
123
2.30
4.05
3.1
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
23
93
2.50
3.97
1.5
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
151
2.14
3.92
1.7
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
11
7.31
3.86
2.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
336
2752
1.29
3.85
4.0
3.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
170
1260
1.39
3.85
3.0
4.2
ug/l
17.2
20.1
0.07
135
1025
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
133
2.20
3.81
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
65
1039
0.61
3.80
1.3
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
16
5.65
3.66
4.8
5.4
—
—
—
0
0
(4306422)
33
163
2.05
3.62
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
34
170
2.02
3.61
2.5
2.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
24
104
2.33
3.60
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
257
1.82
3.53
2.1
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
31
151
2.08
3.53
1.7
1.5
%
53.3
60.6
0.40
21
100
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
165
2.02
3.51
1.2
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
22
93
2.39
3.49
1.4
1.1
—
73.3
—
0
10
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
31
3.57
3.48
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
29
139
2.11
3.44
1.1
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
100
2.32
3.44
1.7
2.3
ml
646.5
630.5
0.05
13
65
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
186
1426
1.35
3.42
2.5
1.8
%
1.6
1.5
0.72
164
1241
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
18
5.02
3.37
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
27
3.72
3.35
2.4
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
12
37
3.26
3.34
2.0
1.2
%
20.1
34.7
1.14
12
32
(3007461) Platelets [#/volume] in Blood
1388
13463
1.46
3.33
45.4
21.0
e9/l
248.9
249.0
0.01
1360
13106
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
148
2.05
3.32
2.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
148
2.05
3.32
2.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
30
148
2.05
3.32
2.3
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
102
2.27
3.30
6.1
1.7
%
10.4
10.9
0.25
23
102
(3024731) MCV [Entitic volume]
1388
13466
1.45
3.29
45.2
20.9
fl
92.0
91.0
8.83
1372
13260
(3035941) MCH [Entitic mass]
1388
13467
1.45
3.28
45.1
20.8
pg
30.4
30.3
0.47
1371
13259
(3026361) Erythrocytes [#/volume] in Blood
1388
13468
1.45
3.27
45.3
20.9
e12/l
4.3
4.5
17.26
1353
13073
(3005988) Vibrio sp identified in Specimen by Organism specific culture
30
149
2.03
3.26
2.3
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1388
13471
1.45
3.23
45.5
21.0
e9/l
11.6
6.8
25.14
1352
13070
(3016750) Collection duration of Urine
19
78
2.45
3.22
1.6
2.2
min
537.5
486.3
0.82
11
54
(3000963) Hemoglobin [Mass/volume] in Blood
1388
13472
1.45
3.22
45.7
21.1
g/l
130.1
135.1
23.67
1370
13262
(4034850)
17
392
0.43
3.22
32.8
9.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
38
3.18
3.21
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
28
3.59
3.20
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
296
1.71
3.19
2.7
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
112
799
1.43
3.17
1.2
1.2
iu/ml
47.1
151.4
4.89
32
319
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1230
11736
1.28
3.17
5.1
4.6
mmol/l
6.1
6.0
2.16
1124
10645
(3017446) Testosterone [Moles/volume] in Serum or Plasma
123
893
1.41
3.16
2.9
2.2
nmol/l
12.0
12.5
0.32
104
780
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
30
151
2.01
3.16
2.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
26
124
2.12
3.15
1.8
2.2
umol/l
18.5
6.7
0.52
13
87
(3047189) Immunofixation for 24 hour Urine
16
61
2.64
3.14
1.3
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
73
2.48
3.13
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
18
73
2.48
3.13
1.4
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
90
617
1.49
3.13
7.6
3.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
32
166
1.95
3.10
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
49
291
1.71
3.10
1.9
1.7
e6/l
8728.0
12814.3
0.55
32
221
(3011288) Drugs identified in Urine by Screen method
45
261
1.75
3.09
4.9
2.5
—
—
—
0
0
(3001729) Color of Synovial fluid
6
8
7.52
3.05
1.3
1.4
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
8
7.52
3.05
4.8
2.0
ug/g
238.3
152.1
—
6
8
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
62
2.60
3.05
2.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
78
524
1.52
3.00
2.1
1.8
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
5
10.03
2.98
2.2
6.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
55
341
1.64
2.97
1.2
1.3
miu/ml
199.9
231.8
0.28
20
163
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
169
1.91
2.96
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
116
2.09
2.83
1.5
1.4
e6/l
19146.1
163491.7
0.98
13
80
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
90
2.24
2.80
1.3
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
18
4.46
2.79
2.8
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
18
4.46
2.79
2.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
18
4.46
2.79
2.8
1.0
—
—
—
0
0
(3019225) pH of Specimen
155
1194
1.33
2.79
7.2
4.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
23
3.93
2.77
2.7
2.3
umol/l
16.1
17.9
—
9
23
(44813793)
18
78
2.32
2.75
1.2
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
33
181
1.84
2.75
5.1
5.1
umol/l
419.6
364.4
1.30
27
161
(3050129) First trimester maternal screen panel - Serum or Plasma
13
308
0.42
2.68
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
62
408
1.54
2.65
1.6
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
58
376
1.56
2.65
2.6
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
49
305
1.63
2.64
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
106
2.09
2.63
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
25
127
1.99
2.61
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
112
1487
0.73
2.58
10.4
7.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
58
379
1.55
2.57
2.6
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
55
355
1.57
2.56
2.7
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
58
380
1.55
2.54
2.7
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
194
1565
1.28
2.50
23.7
26.1
inr
1.4
1.3
0.14
22
212
(3024522) Salmonella sp identified in Specimen by Organism specific culture
28
151
1.87
2.48
2.4
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
63
2.40
2.46
1.1
1.1
ratio
1.1
1.1
—
8
25
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
55
359
1.55
2.46
1.3
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
79
557
1.44
2.44
1.1
1.1
titre
—
125.5
—
0
12
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
71
1006
0.69
2.42
1.9
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
117
1.98
2.41
1.5
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
8
6.27
2.37
1.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
46
2.62
2.36
2.5
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
17
4.13
2.36
1.7
3.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
37
222
1.68
2.32
2.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
76
538
1.43
2.31
8.0
4.2
mmol/l
24.8
24.9
0.07
71
509
(3037121) Protein [Mass/volume] in Urine
66
456
1.47
2.28
3.0
3.6
g/l
0.4
0.3
0.40
37
194
(3047181) Lactate [Moles/volume] in Blood
56
374
1.52
2.28
6.4
7.5
mmol/l
1.2
1.3
1.45
44
329
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
270
1.61
2.28
3.8
1.5
e6/l
335.2
539.7
0.19
36
218
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
18
3.90
2.25
1.6
3.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
56
376
1.51
2.23
2.7
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
619
1.40
2.22
2.7
2.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
24
3.35
2.18
3.1
1.7
mmol/l
1.2
1.2
—
8
24
(3035320) C reactive protein [Mass/volume] in Body fluid
18
87
2.08
2.17
1.9
2.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
61
2.31
2.15
2.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
364
1.50
2.12
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
23
123
1.88
2.12
5.6
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
25
3.21
2.09
2.6
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
43
277
1.57
2.07
3.2
1.4
mmol/l
3.7
3.8
0.09
37
262
(3014891) Appearance of Pleural fluid
7
20
3.51
2.05
2.3
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
184
1.70
2.05
1.5
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
13
56
2.33
2.05
2.5
2.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
42
270
1.57
2.05
3.8
1.4
e6/l
11.0
22.6
0.40
33
210
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
683
0.66
2.04
1.6
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
303
1.53
2.02
2.5
2.4
ug/min
106.5
99.3
0.06
27
192
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
365
3212
1.18
2.01
1.8
1.7
mmol/l
1.6
1.4
3.48
307
2698
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
104
1.94
2.01
2.6
2.0
u/field
1.5
2.2
—
8
43
(42529406) Shigella sp [Presence] in Stool by Culture
54
369
1.48
2.00
1.3
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
257
0.46
1.98
1.8
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
257
0.46
1.98
1.8
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
256
0.46
1.96
1.8
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
256
0.46
1.96
1.8
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
306
1.52
1.94
1.2
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
11
4.56
1.94
1.2
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
16
3.76
1.93
1.8
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
22
3.19
1.88
1.3
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
22
3.19
1.88
1.3
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
301
1.51
1.86
1.8
1.9
iu/l
4.1
5.3
0.37
18
102
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
28
2.87
1.86
1.3
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
46
2.40
1.85
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
12
4.18
1.82
1.2
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
66
2.13
1.82
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
66
2.13
1.82
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
108
1.86
1.82
1.7
1.4
%
21.7
31.8
0.52
11
71
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
274
0.51
1.80
1.9
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
23
3.05
1.80
1.4
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
99
767
1.31
1.79
8.8
7.8
mmol/l
25.3
24.4
1.27
91
719
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
48
329
1.47
1.78
1.5
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
47
2.35
1.78
2.5
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
54
2.23
1.74
2.0
3.5
umol/l
86.2
99.1
—
6
31
(3032057) Clostridioides difficile [Presence] in Stool
8
30
2.68
1.72
2.4
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
236
2027
1.20
1.72
1.6
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
13
3.85
1.71
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
40
587
0.67
1.71
1.5
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
19
3.17
1.66
1.3
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
19
3.17
1.66
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
31
2.59
1.66
1.3
2.1
—
—
—
0
0
(3019977) pH of Arterial blood
13
62
2.11
1.65
3.2
3.7
ph
7.4
7.4
—
5
17
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
14
3.58
1.61
2.2
1.3
ng/l
37.4
104.9
—
5
14
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
14
3.58
1.61
4.4
6.8
mmol/l
4.7
6.2
—
5
14
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
63
2.07
1.60
4.2
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
70
2.01
1.59
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
183
1.60
1.58
1.6
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
71
1.98
1.54
3.1
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
115
1.75
1.53
1.1
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
15
3.34
1.52
1.0
1.1
u/l
22.5
27.2
—
5
10
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
368
1.40
1.49
1.7
2.1
u/l
12354.9
3873.4
0.38
16
150
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
354
0.62
1.47
1.2
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
16
3.13
1.44
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
79
616
1.30
1.41
4.3
3.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
138
0.43
1.40
8.8
2.1
%
13.4
13.2
—
6
138
(3014051) Protein [Presence] in Urine by Test strip
39
272
1.45
1.38
2.5
2.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
23
2.61
1.37
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
23
2.61
1.37
1.0
3.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
121
998
1.23
1.37
1.5
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
75
1.87
1.34
1.6
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
37
0.00
1.34
0.0
3.6
—
72.8
—
0
30
(3021788) Differential panel - Synovial fluid
33
224
1.48
1.34
1.9
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
266
1.44
1.33
6.7
3.8
mg/l
26.6
27.3
0.04
27
170
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
83
1.82
1.31
1.2
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
43
2.10
1.30
1.0
1.1
miu/ml
2007.7
1605.6
—
9
43
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
54
405
1.35
1.28
1.7
1.6
mu/l
218.6
309.0
3.24
49
366
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
62
1.94
1.28
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
99
1.73
1.27
1.1
1.3
u/ml
0.2
0.6
—
6
50
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
38
271
1.41
1.22
6.9
8.6
mmol/l
11.1
11.4
0.19
33
248
(3018572) Chloride [Moles/volume] in Blood
38
271
1.41
1.22
6.9
8.6
mmol/l
105.8
105.4
0.22
33
248
(4281824)
19
116
1.65
1.21
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
37
2.17
1.21
1.5
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
65
506
1.30
1.21
5.9
5.9
%
2.0
1.6
1.11
59
477
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
212
0.56
1.18
1.8
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
38
2.11
1.18
1.5
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
29
198
1.47
1.17
2.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
92
752
1.24
1.16
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
20
2.50
1.15
1.0
1.2
umol/24h
2.4
1.8
—
5
20
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.0
—
1.0
—
0
18
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
158
1.53
1.15
3.2
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
96
792
1.23
1.12
3.7
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
208
0.57
1.12
1.8
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
21
135
1.56
1.11
1.1
1.1
—
—
—
0
0
(4133840)
7
31
2.26
1.10
1.4
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
201
1.45
1.10
1.7
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
207
0.58
1.10
1.8
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
128
1.57
1.08
1.2
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
24
161
1.50
1.07
1.5
1.4
u/l
33.9
22.9
0.72
18
134
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
198
1751
1.15
1.06
1.5
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
63
499
1.27
1.05
6.1
6.0
%
0.9
0.9
0.02
57
471
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
121
0.49
1.05
1.0
1.0
—
0.5
—
0
34
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
22
2.28
1.03
1.6
1.0
—
—
—
0
0
(4027681)
13
75
1.74
1.03
1.5
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
53
1.89
1.01
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
32
437
0.73
1.01
1.4
1.7
mg/l
4.5
3.0
0.87
24
320
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
35
2.00
1.00
1.6
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
35
2.00
1.00
1.1
2.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
35
2.00
1.00
1.0
2.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
36
1.95
0.97
1.6
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
36
1.95
0.97
1.6
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
54
1.86
0.96
15.1
15.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
77
1.69
0.95
1.4
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
78
1.67
0.91
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1169
11428
1.11
0.88
4.3
4.0
mmol/l
1.4
1.3
6.53
1084
10416
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
126
1098
1.16
0.85
1.9
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
72
1.67
0.85
2.8
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
138
1212
1.15
0.84
1.9
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
274
1.32
0.84
1.7
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
120
1044
1.16
0.83
2.3
2.4
ug/l
7.3
6.8
0.14
99
925
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
171
1.41
0.83
1.4
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
105
1.53
0.81
5.4
5.1
u/ml
19.1
74.6
—
6
33
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
268
1.31
0.79
3.3
3.1
nmol/l
0.8
0.8
0.24
27
210
(4211845)
10
58
1.73
0.79
1.3
2.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
53
1.70
0.75
1.4
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
53
1.70
0.75
1.3
3.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
24
2.09
0.74
1.8
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
75
635
1.19
0.74
1.8
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
38
1.85
0.73
3.9
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
38
1.85
0.73
3.9
2.9
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
38
1.85
0.73
1.7
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
60
1.67
0.72
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
327
1.26
0.71
4.6
4.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
203
1.34
0.71
1.1
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
26
1.93
0.70
2.4
1.7
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
41
1.71
0.70
1.1
1.0
—
3.0
—
0
5
(40761535) Cells panel - Urine sediment
89
1025
0.86
0.69
4.9
3.4
—
—
—
0
0
(1002224) Polysomnography panel
57
476
1.21
0.66
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
28
1.79
0.66
9.2
7.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
197
1.33
0.66
1.1
1.1
u/ml
0.3
2.2
—
10
86
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
120
1.42
0.64
1.1
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1212
11926
1.09
0.62
4.7
4.4
mmol/l
4.4
4.6
8.93
1133
11006
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
30
1.67
0.61
9.4
7.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
147
1332
1.11
0.60
1.6
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1233
12146
1.09
0.59
5.1
4.9
mmol/l
2.6
2.7
6.61
1146
11140
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(44806420)
6
38
1.58
0.54
2.7
2.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
38
1.58
0.54
1.8
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
318
3363
0.93
0.53
4.2
4.3
%
22.9
21.4
1.02
155
1637
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
39
1.54
0.53
2.7
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
39
1.54
0.53
1.3
1.5
ug/l
10.7
8.8
—
6
39
(3017569) Oxygen content in Arterial blood
9
63
1.43
0.52
2.8
3.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
100
1.40
0.52
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
107
966
1.12
0.49
3.4
2.7
ml/min/173m2
60.3
65.8
0.72
57
381
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
45
1.56
0.49
1.9
2.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
22
278
0.79
0.48
1.4
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
95
0.63
0.42
1.3
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
149
1.28
0.42
1.2
1.3
mmol/l
6.6
7.5
0.70
14
105
(46235168) Fasting glucose [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.7
—
6.8
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
1.9
—
3.6
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
79
1.40
0.40
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
60
1.34
0.40
9.1
7.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
70
626
1.12
0.40
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1198
11839
1.06
0.39
4.7
4.4
mmol/l
1.3
1.5
15.76
1114
10855
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
142
1.27
0.38
1.3
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
56
498
1.13
0.36
1.7
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
25
208
1.21
0.35
1.4
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
43
376
1.15
0.35
5.5
4.3
mmol/l
4.0
3.9
0.41
37
349
(1617658) Protocol used for examination of sentinel lymph nodes
12
91
1.32
0.33
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
233
2441
0.95
0.32
2.9
3.1
ug/l
0.8
0.8
0.06
157
1618
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
83
1.33
0.32
1.3
1.6
g/l
0.9
1.0
0.37
11
83
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
141
1499
0.93
0.31
4.0
4.5
%
32.1
32.2
0.03
104
1008
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
463
0.88
0.30
2.0
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
65
1.23
0.27
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
159
1.20
0.26
1.4
1.5
—
—
—
0
0
(3020891) Body temperature
53
482
1.10
0.26
6.2
4.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
413
0.89
0.24
2.3
1.7
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
82
0.73
0.24
1.0
1.0
ng/l
240.5
273.2
—
6
47
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
82
0.73
0.24
1.0
1.0
ng/l
29.3
39.5
—
6
45
(3039443) Prostate specific Ag panel - Serum or Plasma
20
233
0.86
0.24
1.4
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
263
0.87
0.22
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
45
410
1.10
0.22
1.2
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
257.6
—
0
5
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
8
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
49
1.23
0.20
1.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
423
4169
1.02
0.12
4.7
5.0
ug/l
2.1
2.7
1.31
373
3723
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
133
1.13
0.12
2.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
62
594
1.05
0.10
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
101
1040
0.97
0.09
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
54
1.11
0.09
2.8
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
63
0.79
0.08
2.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(4146454)
12
132
0.91
0.06
2.1
2.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1017
10207
0.99
0.06
40.1
18.4
g/l
329.9
332.5
14.09
1008
10122
(4024509)
9
103
0.87
0.06
2.6
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
178
1.07
0.05
1.1
1.1
u/ml
2.2
6.1
—
9
88
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
188
1.06
0.05
1.5
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
425
4224
1.01
0.04
3.3
2.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
139
0.93
0.03
1.5
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
171
1.05
0.03
1.1
1.1
u/ml
0.1
0.9
—
8
72
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
38
371
1.02
0.02
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
216
1.02
0.00
1.4
1.5
—
—
—
0
0
(4094501)
32
324
0.99
0.00
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
265
2648
1.00
0.00
5.0
4.0
kg/l
1.0
1.0
0.87
40
385
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
60
1.00
0.00
1.0
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
66
0.91
0.00
1.2
1.3
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
212.6
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_WHITEBLOODCELLNAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_WHITEBLOODCELLNAS 2.642 [2.33, 3.0] < 0.001
Birth year 0.991 [0.98, 1.0] 0.036

During the follow-up period (1.1.1998 — 31.12.2019), 1292 out of 4517 females with D3_WHITEBLOODCELLNAS died.

Males

Parameter HR [95% CI] p-value
D3_WHITEBLOODCELLNAS 2.552 [2.21, 2.94] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1504 out of 4168 males with D3_WHITEBLOODCELLNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_WHITEBLOODCELLNAS.

N-year risk Females Males
1 0.209% 0.51%
5 1.386% 2.595%
10 3.304% 6.39%
15 6.409% 12.203%
20 10.995% 20.185%

Relationships between endpoints

↥

Index endpoint: D3_WHITEBLOODCELLNAS – Other and unspecified disorders of white blood cells

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data